• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

bioMérieux S.A. (Euronext: BIM)

A world leader in the field of in vitro diagnostics for over 45 years, bioMérieux is present in more than 150 countries through 39 subsidiaries and a large network of distributors. In 2008, revenues reached €1.111 billion with 84% of sales outside of France. bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Our products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM - ISIN: FR0010096479). Other information can be found at www.biomerieux.com. *

 

	Start	1999-09-09 existent
	Group	Mérieux (Group)
	Industry	BIOTECH
	Person	Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)
	Person 2	Bélingard, Jean-Luc (Mérieux 201101– Président Directeur Général before Ipsen CEO + Pierre Fabre + Roche Diagnostics)
	Region	Marcy-l’Étoile, Rhône
	Country	France
	City	69280 Marcy l’Étoile
	Tel	+33-4-7887-2000
		Address record changed: 2018-07-24
Basic data	Employees	H: 10,001 to 50,00 (2017-12-31)
	Currency	EUR
	Annual sales	2,288,200,000 (sales, net, consolidated (2017) 2017-12-31)
	Profit	237,600,000 (2017-12-31)
	Cash	312,100,000 (2017-12-31)
		* Document for �About Section�: bioMérieux S.A.. (1/7/10). "Press Release: Philips and bioMérieux Announce Partnership to Develop and Market Next-generation Handheld Diagnostic Solutions for Point-of-Care". Amsterdam & Marcy l’Etoile.
		Record changed: 2019-04-25

Advertisement

More documents for Mérieux (Group)

• [1] bioMérieux S.A.. (4/24/19). "Press Release: bioMérieux – First-Quarter 2019 Business Review". Marcy l’Étoile....
• [2] bioMérieux S.A.. (4/15/19). "Press Release: “Global-PPS”, a Survey of Antibiotic Use and Bacterial Resistance in Hospitals Worldwide, Tops the 200,000 Patients". Marcy l’Étoile & Antwerp....
• [3] bioMérieux S.A.. (4/1/19). "Press Release: University of Antwerp, bioMérieux, and Wellcome Trust to Coordinate VALUE-Dx, a European Public-Private Partnership to Fight Antimicrobial Resistance through Diagnostics". Antwerp, London & Marcy l’Eoile....
• [4] bioMérieux S.A.. (3/19/19). "Press Release: Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury". Deerfield, IL & Marcy l’Etoile....
• [5] bioMérieux S.A.. (2/27/19). "Press Release: bioMérieux – 2018 Financial Results"....
• [6] bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile....
• [7] bioMérieux S.A.. (11/13/18). "Press Release: bioMérieux Launches the BioFire FilmArray Pneumonia Panels with FDA Clearance and CE Marking". Marcy l’Étoile....
• [8] bioMérieux S.A.. (11/9/18). "Press Release: bioMérieux Acquires a Majority Stake in Hybiome and Strengthens Its Presence Both in China and in the Immunoassay Market". Marcy l’Étoile....
• [9] bioMérieux S.A.. (7/18/18). "Press Release: Second-Quarter 2018 Business Review"....
• [10] bioMérieux S.A.. (5/31/18). "Press Release: bioMérieux Launches Endozyme II GO, an Innovative Test for the Detection of Endotoxins in Pharmaceutical Microbiology Control". Marcy l’Étoile....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.